Rankings
▼
Calendar
REVB Q2 2023 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
REVB
Revelation Biosciences, Inc.
$2M
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$6,262
Operating Income
-$2M
Net Income
-$1M
EPS (Diluted)
$-119.60
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$59,435
Balance Sheet
Total Assets
$16M
Total Liabilities
$5M
Stockholders' Equity
$11M
Cash & Equivalents
$16M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$6,262
-$6,262
+0.0%
Operating Income
-$2M
-$2M
-3.9%
Net Income
-$1M
-$2M
+21.1%
← FY 2023
All Quarters
Q3 2023 →